GLP-1 Medications Now $50/Month for Medicare Beneficiaries
Beginning July 1, 2026, Medicare beneficiaries may have access to significantly lower costs for certain GLP-1 medications through a new CMS initiative called the GLP-1 Bridge Program. For many people, GLP-1 medications such as Wegovy® and Zepbound® have been financially out of reach — often costing more than $1,000 per month. The new program aims […]